EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a New, Potent, and Stable Tetrahydroquinoline-Based 5-LOX/sEH Dual Inhibitor with Polymodal Anti-Inflammatory Activity in Acute Pancreatitis

Danilo D'Avino iD, Tania Ciaglia, Paul M Jordan, Simone Di Micco iD, Simona Musella, Veronica Di Sarno, Fabrizio Merciai, Sara Perna iD, Gerardina Smaldone, Francesca Di Matteo, Valeria Napolitano, Rosario Stimoli und 18 weitere

Journal of Medicinal Chemistry · 13.08.2026 · 69 (15) · 19162-19186

DOI: 10.1021/acs.jmedchem.6c01458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.07.2026. Verfasst von Danilo D'Avino und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via D. Montesano 49, 80131Naples, Italy. Hauptthemen laut MEDLINE: Lipoxygenase Inhibitors, Pancreatitis, Quinolines, Epoxide Hydrolases. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Freistaat Th?ringen, European Commission, Ministero dell?Istruzione, dell?Universit? e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute pancreatitis (AP) is a common, serious, pancreatic inflammation representing an unmet therapeutical need. Here, we report the design and synthesis of a series of compounds as dual 5-lipoxygenase (LOX)/soluble epoxide hydrolase (sEH) inhibitors aimed at favorably modulating inflammatory lipid mediator pathways. The tetrahydroquinoline-based compound 11 emerged as the most promising candidate, showing potent in vitro inhibition of both enzymes and satisfactory metabolic stability. Compound 11 was evaluated in a cerulein-induced murine model of AP, where it significantly reduced pancreatic damage, cellular infiltration, and edema formation. These effects led to beneficial modulation of LMs and attenuation of ferroptosis, concomitant with activation of the Nrf2 antioxidant pathway and upregulation of cytoprotective markers. Compound 11 ameliorated lung, liver, and kidney secondary damage, displaying an improved in vivo pharmacokinetic profile. Overall, these findings reveal compound 11 as a promising anti-inflammatory agent supporting dual 5-LOX/sEH inhibition, coupled with Nrf2 activation, as a viable strategy for AP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoxygenase InhibitorsPancreatitisQuinolinesEpoxide HydrolasesArachidonate 5-LipoxygenaseAnti-Inflammatory AgentsAnimalsMiceMaleHumansStructure-Activity RelationshipNF-E2-Related Factor 2CeruletideAcute DiseaseMice, Inbred C57BL

Substanzen

Lipoxygenase InhibitorsQuinolinesEpoxide HydrolasesArachidonate 5-LipoxygenaseAnti-Inflammatory AgentsNF-E2-Related Factor 21,2,3,4-tetrahydroquinolineCeruletide

Autor:innen und Institutionen

  • Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via D. Montesano 49, 80131Naples, Italy.
  • Department of Pharmacy, University of Salerno, Via G. Paolo II 132, 84084Fisciano, SalernoItaly.
  • Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Philosophenweg 14, D-07743Jena, Germany.
  • European Biomedical Research Institute of Salerno (EBRIS), Via S. De Renzi 50, 84125Salerno, Italy.
  • National PhD Program in ″RNA Therapeutics and Gene Therapy″, 80131Naples, Italy.
  • Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", P.zza L. Miraglia, 2, 80138Naples, Italy.

ORCID-Profile: Danilo D'Avino, Simone Di Micco, Sara Perna, Ignazio Sardo, Giuseppe Bifulco, Eduardo Maria Sommella, Giovanna Aquino, Giacomo Pepe, Isabel M Gomez-Monterrey, Pietro Campiglia, Carmine Ostacolo, Michele Manfra, Oliver Werz, Alessia Bertamino

Förderung

  • Freistaat Th?ringen
  • European Commission
  • Ministero dell?Istruzione, dell?Universit? e della Ricerca
  • Th?ringer Aufbaubank
  • Ministero dell'Istruzione e del Merito
  • German Research Council (DFG)

Zitieren

APA

D'Avino, D., Ciaglia, T., Jordan, P. M., Di Micco, S., Musella, S., Di Sarno, V., Merciai, F., Perna, S., Smaldone, G., Di Matteo, F., Napolitano, V., Stimoli, R., Sardo, I., Ricci, O., Bifulco, G., Sommella, E. M., Basilicata, M. G., Ferrara, G., Roviezzo, F., …, & Bertamino, A. (2026). Identification of a New, Potent, and Stable Tetrahydroquinoline-Based 5-LOX/sEH Dual Inhibitor with Polymodal Anti-Inflammatory Activity in Acute Pancreatitis. Journal of Medicinal Chemistry, 69(15), 19162-19186. https://doi.org/10.1021/acs.jmedchem.6c01458

Vancouver

D'Avino D, Ciaglia T, Jordan PM, Di Micco S, Musella S, Di Sarno V, et al. Identification of a New, Potent, and Stable Tetrahydroquinoline-Based 5-LOX/sEH Dual Inhibitor with Polymodal Anti-Inflammatory Activity in Acute Pancreatitis. Journal of Medicinal Chemistry. 2026;69(15):19162-19186. doi:10.1021/acs.jmedchem.6c01458

BibTeX
@article{DAvino2026,
  author = {D'Avino, Danilo and Ciaglia, Tania and Jordan, Paul M and Di Micco, Simone and Musella, Simona and Di Sarno, Veronica and Merciai, Fabrizio and Perna, Sara and Smaldone, Gerardina and Di Matteo, Francesca and Napolitano, Valeria and Stimoli, Rosario and Sardo, Ignazio and Ricci, Ornella and Bifulco, Giuseppe and Sommella, Eduardo Maria and Basilicata, Manuela Giovanna and Ferrara, Giovanni and Roviezzo, Fiorentina and Di Dio, Anna and Aquino, Giovanna and Pellecchia, Sofia and Pepe, Giacomo and Gomez-Monterrey, Isabel M and Campiglia, Pietro and Ostacolo, Carmine and Manfra, Michele and Werz, Oliver and Rossi, Antonietta and Bertamino, Alessia},
  title = {Identification of a New, Potent, and Stable Tetrahydroquinoline-Based 5-LOX/sEH Dual Inhibitor with Polymodal Anti-Inflammatory Activity in Acute Pancreatitis},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {15},
  pages = {19162--19186},
  doi = {10.1021/acs.jmedchem.6c01458}
}
Kostenlos starten →